270 related articles for article (PubMed ID: 31402751)
1. Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes.
Xiao X; Tang A; Cox KS; Wen Z; Callahan C; Sullivan NL; Nahas DD; Cosmi S; Galli JD; Minnier M; Verma D; Babaoglu K; Su H; Bett AJ; Vora KA; Chen Z; Zhang L
MAbs; 2019; 11(8):1415-1427. PubMed ID: 31402751
[TBL] [Abstract][Full Text] [Related]
2. A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus
Bar-Peled Y; Diaz D; Pena-Briseno A; Murray J; Huang J; Tripp RA; Mousa JJ
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292250
[TBL] [Abstract][Full Text] [Related]
3. Profiling of hMPV F-specific antibodies isolated from human memory B cells.
Xiao X; Fridman A; Zhang L; Pristatsky P; Durr E; Minnier M; Tang A; Cox KS; Wen Z; Moore R; Tian D; Galli JD; Cosmi S; Eddins MJ; Sullivan NL; Yan X; Bett AJ; Su HP; Vora KA; Chen Z; Zhang L
Nat Commun; 2022 May; 13(1):2546. PubMed ID: 35538099
[TBL] [Abstract][Full Text] [Related]
4. Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.
Mousa JJ; Binshtein E; Human S; Fong RH; Alvarado G; Doranz BJ; Moore ML; Ohi MD; Crowe JE
PLoS Pathog; 2018 Feb; 14(2):e1006837. PubMed ID: 29470533
[TBL] [Abstract][Full Text] [Related]
5. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein.
Mousa JJ; Kose N; Matta P; Gilchuk P; Crowe JE
Nat Microbiol; 2017 Jan; 2():16271. PubMed ID: 28134924
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
Patel N; Massare MJ; Tian JH; Guebre-Xabier M; Lu H; Zhou H; Maynard E; Scott D; Ellingsworth L; Glenn G; Smith G
Vaccine; 2019 Sep; 37(41):6112-6124. PubMed ID: 31416644
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
[TBL] [Abstract][Full Text] [Related]
8. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.
Corti D; Bianchi S; Vanzetta F; Minola A; Perez L; Agatic G; Guarino B; Silacci C; Marcandalli J; Marsland BJ; Piralla A; Percivalle E; Sallusto F; Baldanti F; Lanzavecchia A
Nature; 2013 Sep; 501(7467):439-43. PubMed ID: 23955151
[TBL] [Abstract][Full Text] [Related]
9. Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells.
Cortjens B; Yasuda E; Yu X; Wagner K; Claassen YB; Bakker AQ; van Woensel JBM; Beaumont T
J Virol; 2017 May; 91(10):. PubMed ID: 28275185
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus.
Banerjee A; Huang J; Rush SA; Murray J; Gingerich AD; Royer F; Hsieh CL; Tripp RA; McLellan JS; Mousa JJ
Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2203326119. PubMed ID: 35696580
[TBL] [Abstract][Full Text] [Related]
11. A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.
Schuster JE; Cox RG; Hastings AK; Boyd KL; Wadia J; Chen Z; Burton DR; Williamson RA; Williams JV
J Infect Dis; 2015 Jan; 211(2):216-25. PubMed ID: 24864121
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein.
Mousa JJ; Sauer MF; Sevy AM; Finn JA; Bates JT; Alvarado G; King HG; Loerinc LB; Fong RH; Doranz BJ; Correia BE; Kalyuzhniy O; Wen X; Jardetzky TS; Schief WR; Ohi MD; Meiler J; Crowe JE
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6849-E6858. PubMed ID: 27791117
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus.
Wen X; Mousa JJ; Bates JT; Lamb RA; Crowe JE; Jardetzky TS
Nat Microbiol; 2017 Jan; 2():16272. PubMed ID: 28134915
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater
Zhao M; Zheng ZZ; Chen M; Modjarrad K; Zhang W; Zhan LT; Cao JL; Sun YP; McLellan JS; Graham BS; Xia NS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539438
[TBL] [Abstract][Full Text] [Related]
15. A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein.
Huang J; Miller RJ; Mousa JJ
Front Immunol; 2022; 13():941865. PubMed ID: 36003370
[TBL] [Abstract][Full Text] [Related]
16. Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.
Fedechkin SO; George NL; Nuñez Castrejon AM; Dillen JR; Kauvar LM; DuBois RM
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852779
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitope.
McCool RS; Musayev M; Bush SM; Derrien-Colemyn A; Acreman CM; Wrapp D; Ruckwardt TJ; Graham BS; Mascola JR; McLellan JS
J Virol; 2023 Oct; 97(10):e0092923. PubMed ID: 37737588
[TBL] [Abstract][Full Text] [Related]
19. Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition mode.
Wen X; Suryadevara N; Kose N; Liu J; Zhan X; Handal LS; Williamson LE; Trivette A; Carnahan RH; Jardetzky TS; Crowe JE
Cell Host Microbe; 2023 Aug; 31(8):1288-1300.e6. PubMed ID: 37516111
[TBL] [Abstract][Full Text] [Related]
20. Antibody recognition of the Pneumovirus fusion protein trimer interface.
Huang J; Diaz D; Mousa JJ
PLoS Pathog; 2020 Oct; 16(10):e1008942. PubMed ID: 33035266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
